Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Trillium Therapeutics Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT01559961
- Locations
- 🇨🇦
Bramalea Medical Centre, Brampton, Ontario, Canada
🇨🇦The Fe/Male Health Centres, Oakville, Ontario, Canada
🇨🇦Urology & Male Fertility Clinic, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath